
Keywords: CMV; cytomegalovirus; CRP; C-reactive protein; EAD; early graft dysfunction; ESLD; end-stage liver diseases; HBV; hepatitis B virus; HCV; hepatitis C virus; HIV; human immunodeficiency virus; IDO; indoleamine 2,3-dioxygenase; IFN; Interferon; MELD; Model